Your browser doesn't support javascript.
loading
The alarmin IL-33 promotes regulatory T-cell function in the intestine.
Schiering, Chris; Krausgruber, Thomas; Chomka, Agnieszka; Fröhlich, Anja; Adelmann, Krista; Wohlfert, Elizabeth A; Pott, Johanna; Griseri, Thibault; Bollrath, Julia; Hegazy, Ahmed N; Harrison, Oliver J; Owens, Benjamin M J; Löhning, Max; Belkaid, Yasmine; Fallon, Padraic G; Powrie, Fiona.
Afiliação
  • Schiering C; Translational Gastroenterology Unit, Nuffield Department of Clinical Medicine, Experimental Medicine Division, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK.
  • Krausgruber T; Translational Gastroenterology Unit, Nuffield Department of Clinical Medicine, Experimental Medicine Division, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK.
  • Chomka A; Translational Gastroenterology Unit, Nuffield Department of Clinical Medicine, Experimental Medicine Division, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK.
  • Fröhlich A; Experimental Immunology, Department of Rheumatology and Clinical Immunology, Charité - University Medicine Berlin, and German Rheumatism Research Center (DRFZ), Berlin, Germany.
  • Adelmann K; Translational Gastroenterology Unit, Nuffield Department of Clinical Medicine, Experimental Medicine Division, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK.
  • Wohlfert EA; Program in Barrier Immunity and Repair, Mucosal Immunology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.
  • Pott J; Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford, OX1 3RE, United Kingdom.
  • Griseri T; Translational Gastroenterology Unit, Nuffield Department of Clinical Medicine, Experimental Medicine Division, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK.
  • Bollrath J; Translational Gastroenterology Unit, Nuffield Department of Clinical Medicine, Experimental Medicine Division, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK.
  • Hegazy AN; Translational Gastroenterology Unit, Nuffield Department of Clinical Medicine, Experimental Medicine Division, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK.
  • Harrison OJ; Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford, OX1 3RE, United Kingdom.
  • Owens BMJ; Translational Gastroenterology Unit, Nuffield Department of Clinical Medicine, Experimental Medicine Division, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK.
  • Löhning M; Experimental Immunology, Department of Rheumatology and Clinical Immunology, Charité - University Medicine Berlin, and German Rheumatism Research Center (DRFZ), Berlin, Germany.
  • Belkaid Y; Program in Barrier Immunity and Repair, Mucosal Immunology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.
  • Fallon PG; Trinity Biomedical Sciences Institute, Trinity College Dublin, Pearse Street, Dublin, Ireland.
  • Powrie F; Translational Gastroenterology Unit, Nuffield Department of Clinical Medicine, Experimental Medicine Division, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK.
Nature ; 513(7519): 564-568, 2014 Sep 25.
Article em En | MEDLINE | ID: mdl-25043027

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucinas / Linfócitos T Reguladores / Intestinos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Nature Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucinas / Linfócitos T Reguladores / Intestinos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Nature Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Reino Unido